Quality of screening with conventional Pap smear in Austria - A longitudinal evaluation

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Rásky, Éva ^a   Regitnig, Peter ^a,b   Schenouda, Michél ^a   Burkert, Nathalie ^a   Freidl, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Austrian Society of Cytology   (Austria)

Author keywords

Austria; Pap smear; Quality assurance; Screening; Self monitoring

Indexed keywords

EID: 84886005488     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-998     Document Type: Article

References (35)

1. Zielonke N, Krebsinzidenz und Krebsmortalität in Österreich Vienna: Statistics Austria 2010 65 67
2. Statistics Austria, Krebserkrankungen Vienna: Statistics Austria 2012 http://www.statistik.at/web-de/statistiken/gesundheit/krebserkrankungen/ gebaermutterhals/index.html; accessed 28§ssup§th§esup§ October 2013
3. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, Naghavi M, Lancet 2011 378 1461 1484 10.1016/S0140-6736(11) 61351-2 21924486
4. BMG / Federal Ministry of Health, Österreichischer Impfplan Vienna: BMG 2013 http://bmg.gv.at/cms/home/attachments/3/3/6/CH1100/CMS1327680589121/ impfplan2013.pdf; accessed 3§ssup§th§esup§ July 2013
5. USPSTF / US Preventive Services Task Force, Guide to clinical preventive services Washington DC: US Department of Health and Human Services 1996
6. Cervical cancer screening in Austria. Breitenecker G, Wiener H, Stani J, Eur J Cancer 2000 36 2189 2190 10.1016/S0959-8049(00)00322-1 11072202
7. Description of the national situation of cervical cancer-Austria. Wiener HG, Rásky É Horvat R, Eur J Cancer 2009 45 2686
8. Cytopathology in Austria. Breitenecker G, Dinges HP, Regitnig P, Wiener H, Vutuc C, Cytopathology 2004 15 113 118 10.1111/j.1365-2303.2004.00125.x 15056173 (Pubitemid 38482599)
9. European Commission / EC, European guidelines for quality assurance in mammography screening Luxembourg: EC 2006
10. European Commission / EC, European guidelines for quality assurance in cervical screening Luxembourg: EC 2008
11. European Commission / EC, European guidelines for quality assurance in colorectal cancer screening and diagnosis Luxembourg: EC 2011
12. European Parliament, Resolution of 10 April 2008 on combating cancer in the enlarged European Union, P6-TA(2008)0121 Brussels: EU http://www.europarl. europa.eu/sides/getDoc.do?type=TA&reference=P6-TA-2008-0121&format= XML&language=EN; accessed 28§ssup§th§esup§ October 2013
13. European Commission / EC, Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening Luxembourg: EC 2008
14. Zervixzytologische Nomenklatur und Befundwiedergabe-Neue Leitlinie der Österreichischen Gesellschaft für Zytologie. Breitenecker G, Dinges HP, Regitnig P, Gyn-aktiv 2006 4 36 37 http://www.cytology.at/pdf/Leitlinien- Nomenklatur.pdf; accessed 16§ssup§th§esup§ Oct 2013
15. Regitnig P, Breitenecker G, Dinges HP, et al. Leitlinie zur Qualität in der gynäkologischen Zytologie. ARGE Qualitätssicherung der Österreichischen Gesellschaft für Zytologie und Österreichische Gesellschaft für Pathologie 2013 http://www.cytology.at/pdf/20130401-OEGZ- OEGP-Leitlinie-zur-Qualitaet-in-der-gynaekologischen-Zytologie-2013.pdf; accessed 3§ssup§th§esup§ July 2013
16. Früherkennung des Zervixkarzinoms: das Kärntner Qualitätssicherungsprogramm Ergebnisse der Nachkontrolle gynäkologisch-zytologischer Abstriche von Patientinnen mit invasiven Zervixkarzinomen. Dinges HP, Regitnig P, Ropp E, Fladerer H, Moinfar F, Breitenecker G, Frauenarzt 2006 47 724 729
17. Rásky É Report "Qualitätsoffensive PAP-Abstrich", by contract for the Association of Social Insurance Providers Vienna: HSV 2007
18. Reevaluation of cytological smears in patients with cervical cancer. Regional quality assurance program with the cooperation of the Austrian Society of Cytology, the Carinthian Medical Association and the Carinthian Ministry of Health. Regitnig P, Dinges HP, Ropp E, Fladerer H, Moinfar F, Breitenecker G, Pathologe 2007 28 5 339 345 10.1007/s00292-007-0931-9 17653718 (Pubitemid 47373369)
19. Regitnig P, Wilfing C, WGKK Projekt zur PAP-Abstrich-Optimierung Vienna: WGKK 2008
20. Quality of conventional Pap smears. Quality assessment and motivation for improvement. Regitnig P, Nader A, Wiener H, Pathologe 2012 33 4 293 300 10.1007/s00292-012-1574-z 22569927
21. ÖGZ / Österreichische Gesellschaft für Zytologie, Jahresbericht 2010
22. Der PAP-Abstrich. Reiner-Concin A, Österreichische Ärztezeitung 2011 7 26 38
23. Cost of screening and treatment of cervical dyscaryosis in Germany. Petry KU, Breugelmann JG, Bénard S, Lamure E, Littlewood KJ, Hillemanns P, Eur J Gynaecol Oncol 2008 29 4 345 349 18714567
24. The German Cervical Cancer Screening Model: development and validation of a decision-analytic model for cervical cancer screening in Germany. Siebert U, Sroczynski G, Hillemanns P, Engel J, Stabenow R, Stegmaier C, Voigt K, Gibis B, Hölzel D, Goldie SJ, Eur J Public Health 2006 16 2 185 92 16469759
25. Cost-effectiveness of primary HPV screening for cervical cancer in Germany-a desicion analysis. Sroczynski G, Schnell-Inderst P, Mühlberger N, Lang K, Aidelsburger P, Wasem J, Mittendorf T, Engel J, Hillemanns P, Petry KU, Krämer A, Sibert U, Eur J Cancer 2011 47 1633 1646 10.1016/j.ejca.2011.03. 006 21482103
26. Screening auf Zervixkarzinom. Mühlhauser I, Filz M, arznei-telegramm 2008 3 1 38
27. Bortz J, Lienert GA, Böhnke K, Verteilungsfreie Methoden in der Biostatistik Berlin, Heidelberg: Springer Verlag 1990
28. Fixed- and random-effects models in meta-analysis. Hedges LV, Vevea JL, Psychol Methods 1998 3 486 504 (Pubitemid 128459639)
29. Statistics Austria, Bevölkerung nach Geschlecht Vienna: Statistics Austria 2013 http://www.statistik.at/web-de/statistiken/bevoelkerung/ bevoelkerungsstruktur/bevoelkerung-nach-alter-geschlecht/index.html; accessed 3§ssup§th§esup§ July 2013
30. Pap smears and screening for cervical neoplasia. Wilkinson EJ, Clin Obstet Gynecol 1990 33 817 825 10.1097/00003081-199012000-00017 2289348
31. Reasons for cervical cancer despite extensive screening. Stenkvist B, Soderstrom J, J Med Screen 1996 3 204 207 9041486 (Pubitemid 126736093)
32. Evaluation of cervical cytology. McCrory D, Matchar D, Bastian L, Datta S, Hasselblad V, Hickey J, Myers E, Nanda K, Evid Rep Technol Assess (Summ) 1999 5 1 6 11925972
33. The predicted effect of changes in cervical screening practice in the UK: results from a modeling study. Canfell K, Barnabas R, Patnick J, Beral V, Br J Cancer 2004 91 3 530 536 10.1038/sj.bjc.6602002 15266332 (Pubitemid 39093574)
34. Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years. Creighton P, Lew JB, Clements M, Smith M, Howard K, Dyer S, Lord S, Canfell K, BMC Public Health 2010 10 734 doi:10.1186/1471-2458-10-734 10.1186/1471-2458-10-734 21110881
35. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J, Vaccine 2006 24 Suppl 3 78 89